Business · 04/12/2014
FDA Releases Draft Guidance for Labeling of Human Prescription Drugs and Biological Products
The FDA has published a draft guidance to help pharmaceutical companies comply with new labeling requirements for human prescription drugs and biological products, particularly those related to pregnancy, lactation, and reproductive potential.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →